PRIOR AUTHORIZATION POLICY Tecfidera® (dimethyl fumarate delayed-release capsules Biogen Idec) To Initiate a Coverage Review, Call[removed]

First Page		Document Content
Date: 2014-01-29 12:47:07 Medicine Immunosuppressants Autoimmune diseases Cytokines Treatment of multiple sclerosis Glatiramer acetate Interferon beta-1a Natalizumab Biogen Idec Immunology Multiple sclerosis Immune system		PRIOR AUTHORIZATION POLICY Tecfidera® (dimethyl fumarate delayed-release capsules Biogen Idec) To Initiate a Coverage Review, Call[removed] Add to Reading List Source URL: statehealthplan.state.nc.us Download Document from Source Website File Size: 164,77 KB Share Document on Facebook

	Bone Marrow Transplantation, (, 631–638  1997 Stockton Press All rights reserved 0268– $12.00 Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first res DocID: 1skpp - View Document
	Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2 DocID: 1rmwo - View Document
	Hyperbaric Oxygen Therapy for Multiple Sclerosis: My Experience William S. Maxfield, M.D. The use of hyperbaric oxygen therapy (HBOT) for treatment of multiple sclerosis was advocated by Richard A. Neubauer, M.D., in the DocID: 1qui7 - View Document
	CLINICAL TRIALS FUNDED BY THE NATIONAL MS SOCIETY Updated January 2016 Abbreviations Key: AAN – American Academy of Neurology ECTRIMS – European Committee for Treatment and Research in Multiple Sclerosis DocID: 1osEZ - View Document
	For people with relapsing forms of multiple sclerosis (MS) Injection Guide for Treatment With the AVONEX PEN® For important safety information, please see pagesand the full Prescribing Information, DocID: 1mflc - View Document